Validity Test of Wearable Continuous Blood Pressure Measuring System

  • STATUS
    Recruiting
  • participants needed
    220
  • sponsor
    Yonsei University
Send
Updated on 16 February 2024
See if I qualify

Summary

  1. Purpose of Research For the feasibility test of a wearable blood pressure measuring device, biometric data of patients in surgical intensive care is simultaneously obtained and stored from the device and a patient monitor.
  2. Overview of Research Design This research is simply to obtain and store the data: 1) invasive arterial blood pressure measured with a patient monitor from one wrist, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device from the other wrist.
  3. Medical Device for Clinical Trial Patient monitor (IntelliVue MX700, Philips, NED) and wearable blood pressure measuring device
  4. Target Recruiting Number of Participants Considering the expected patient number in intensive care and 10% dropout rate during the research period, the target recurring number of participants is 220.
  5. Criteria of Participant Inclusion
    1. Adult patient in surgical intensive care of Severance Hospital
    2. Voluntarily agreed to participate the research and not included to the exclusion criteria
    3. Criteria of Participant Exclusion
    4. Patient with occlusive peripheral arterial disease
    5. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
    6. Patient administered high-dose of pressor agent over 15 mcg/min
    7. Patient who is not available for measurement of invasive arterial blood pressure
    8. Patient who is not available to wear an wearable device on the wrist
    9. Pregnant woman, minor
    10. Evaluation Parameter
    11. Systolic and diastolic blood pressure, which extracted in mmHg unit from the continuous blood pressure output of patient monitor.
    12. Blood pressure, which estimated by the signal analysis of multi-wavelength photoplethysmography and pressure signal measured with the wearable device.
    13. Data Analysis and Statistical Methods
    14. From the multi-wavelength photoplethysmography and multi-channel pressure signal measured, continuous blood pressure will be estimated through the hemodynamic model and machine learning model.
    15. For the machine learning model, the data obtained will be divided into the training data and evaluation data, with the ratio of 80% and 20%.
    16. In order to evaluate the accuracy of the estimated blood pressure, the invasive arterial blood pressure will be considered as the reference blood pressure. Between the estimated blood pressure and the reference blood pressure, the correlation and root mean square error (RMSE) will be calculated.

Description

  1. Recruit participants.
  2. Explain the research purpose and details, and then have the participant sign the consent form.
  3. Before starting the measurement, gather the participant's information such as age, length, and weight.
  4. Measure noninvasive blood pressure in both arms. Compared to the blood pressure in the arm where inserted a catheter, confirm if difference of systolic or diastolic blood pressure in the other side of arm is not more than 10%.
  5. Wear the wearable device on the opposite wrist from the catheter-inserted.
  6. For 10 minutes, simultaneously obtain the data: 1) invasive arterial blood pressure measured with a patient monitor, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device.
  7. For accuracy of data acquisition, repeat twice the procedure 5-7 by performing it in the morning and in the afternoon with the 5 hours interval.

Details
Condition Patients in Surgical Intensive Care
Age 18years - 100years
Clinical Study IdentifierNCT04261062
SponsorYonsei University
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Adult patient in surgical intensive care of Severance Hospital

Exclusion Criteria

Exclusion Criteria
Patient with occlusive peripheral arterial disease
Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
Patient administered high-dose of pressor agent over 15 mcg/min
Patient who is not available for measurement of invasive arterial blood pressure
Patient who is not available to wear an wearable device on the wrist
Pregnant woman, minor
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.